Dec. 2, 2019
CONTACT: Lynn Sutfin, 517-241-2112
LANSING, Mich. – Starting today, the Michigan Department of Health and Human Services (MDHHS) Medical Services Administration has removed prior authorization requirements for medications used to treat opioid use disorder, including buprenorphine.
"The removal of prior authorization for these medications in the Medicaid program will help increase access to treatment for people with opioid use disorders," said Dr. Joneigh Khaldun, chief medical executive and chief deputy for health for MDHHS. "By eliminating this requirement, medical providers will be empowered to help people begin treatment when they are ready and increase their chances of a successful recovery."
Prior authorization is a requirement that physicians must obtain approval from a patient's health care insurer before prescribing a specific medication or to perform a particular operation.
After an in-depth analysis of the prior authorization program, existing literature and lessons learned in other states, MDHHS believes that prior authorization creates substantially more barriers to accessing care for opioid use disorders than protections from misuse of substances.
More on Michimich.com
Medication-assisted treatment, combined with counseling or behavioral therapy, is the gold standard for treating individuals with opioid use disorder, leading to significantly better outcomes. Prior authorization has been removed in 21 states with no data indicating an increased rate of drug diversion.
MDHHS will conduct an evaluation and complete quarterly monitoring of drug utilization claims to assess changes in how the medications are used to treat patients and ensure that the change does not result in any negative impacts.
More information is available in a Frequently Asked Questions document.
For more information on the opioid epidemic and efforts being made by the state to address this issue, visit Michigan.gov/Opioids.
CONTACT: Lynn Sutfin, 517-241-2112
LANSING, Mich. – Starting today, the Michigan Department of Health and Human Services (MDHHS) Medical Services Administration has removed prior authorization requirements for medications used to treat opioid use disorder, including buprenorphine.
"The removal of prior authorization for these medications in the Medicaid program will help increase access to treatment for people with opioid use disorders," said Dr. Joneigh Khaldun, chief medical executive and chief deputy for health for MDHHS. "By eliminating this requirement, medical providers will be empowered to help people begin treatment when they are ready and increase their chances of a successful recovery."
Prior authorization is a requirement that physicians must obtain approval from a patient's health care insurer before prescribing a specific medication or to perform a particular operation.
After an in-depth analysis of the prior authorization program, existing literature and lessons learned in other states, MDHHS believes that prior authorization creates substantially more barriers to accessing care for opioid use disorders than protections from misuse of substances.
More on Michimich.com
- Michigan: Lane closures for Portage Lake Lift Bridge inspection set for June 10
- Michigan Issues Payments to Utilities for Low-income Customers to Help Them Keep Their Energy Services Connected During COVID-19
- Governor Whitmer Rescinds Safer at Home Order, Moves Michigan to Phase Four of the MI Safe Start Plan
- Michigan: Gov. Whitmer Calls for Unity Following President Trump's Call for Governors to 'Dominate' Protesters
- Pomegranate Pictures Attaches Hollywood Vet Sam Sako
Medication-assisted treatment, combined with counseling or behavioral therapy, is the gold standard for treating individuals with opioid use disorder, leading to significantly better outcomes. Prior authorization has been removed in 21 states with no data indicating an increased rate of drug diversion.
MDHHS will conduct an evaluation and complete quarterly monitoring of drug utilization claims to assess changes in how the medications are used to treat patients and ensure that the change does not result in any negative impacts.
More information is available in a Frequently Asked Questions document.
For more information on the opioid epidemic and efforts being made by the state to address this issue, visit Michigan.gov/Opioids.
0 Comments
Latest on Michimich.com
- Los Angeles Based, 8th Floor LLC & ChildFaceMask.com Give Back to the Community While Protecting Children from COVID-19, Viruses, Allergies, & more
- Michigan: Rumble strip installation on I-75 starts tomorrow in northern Oakland County
- New Manufacturers' Resource: Dynamic Improvement Group Works to Boost Factory Efficiencies
- OCI Announces Appointment of Dr. Luke Matranga, Former President of Academy of General Dentistry, to OCI Dental Advisory Board
- Limitless Herbal Ltd Closes on Multi-Million Dollar CBD Deal
- ASCEND 2020 Atlanta Alumni pivot, to create Joint Venture RTW (Return to Work) Solutions Group to provide COVID-19 Business Services
- Little Caesars Popular Crazy Bread® Gets Gooey, Melty, Cheesy Spin-Off
- Real Estate Loans Are Closing During Global Pandemic. Just Ask Rickey Biddle of Philadelphia
- Michigan: Northbound M-39 service drive and ramps closing at US-12 for three weeks for bridge work
- Michigan: Northbound M-24 closing at Drahner Road as work begins in downtown Oxford in northern Oakland County
- Michigan: Secretary Benson: Don't miss June 1 deadline to apply for the Independent Citizens Redistricting Commission
- Michigan: Big Beaver Road to close under I-75 Monday night in Oakland County for new bridge deck concrete pour
- MI Symptoms Web Application Helps Michiganders Track Symptoms; Informs Reopening Strategy
- Michigan regional jobless rates surge in April with COVID-19 pandemic
- Michigan: Lawmakers Sponsor Upcoming Auto Insurance Town Halls
- STARK Industries, LLC Awarded NASA JPL - VITAL Ventilator Manufacturing License to Combat the Global COVID-19 Crisis
- Proposed 2020-21 Sterling Heights Budget Funds Critical Needs with No Tax Increase
- Evolve IP Offers Rapid Deployment of Desktop as a Service to Ingram Micro Partners
- Michigan: AG Nessel Supports Legislative Effort to Re-engage Economy Safely
- Michigan: MDARD Director Statement Regarding $22.5 Million Rural Broadband Investment from USDA